Advertisement
Person › Details
David Bejker (Affibody Medical AB)
Bejker, David (Affibody 201207 CEO before HealthCap)
Organisation | Affibody Medical AB | |
Former/major organisation | HealthCap Advisor AB | |
Group | Odlander Fredrikson (Group) | |
Product | Affibody® molecule | |
Product 2 | IL-1 inhibitor | |
Record changed: 2022-12-25 |
Advertisement
More documents for David Bejker
- [1] European Invesmtent Bank (EIB). (12/23/22). "Press Release: Sweden – EIB Lends €20 Million to Biotech Company for Development of Biopharmaceuticals to Treat Cancer and Inflammatory Diseases"....
- [2] Affibody Medical AB. (12/23/22). "Press Release: Affibody Signs €20 Million Loan Agreement with the EIB to Finance the Development of Next Generation’s Biopharmaceuticals against Cancer and Inflammatory Diseases". Solna....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top